ClinicalTrials.govpublic full text
Impact of a TDM-guided ECPA Program for Optimizing Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam-based Regimen
liver transplant infection
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 127637
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.